立基工程控股(01690.HK)拟折让20%配售2亿股 筹资1170万港元
格隆汇4月27日丨立基工程控股(01690.HK)发布公告,于2021年4月27日,公司与配售代理订立配售协议,公司拟配售最多2亿股,相当于现有已发行股本15.0%,及经配发扩大后的公司已发行股本约13.1%。每股配售股份的配售价0.06港元,较4月27日收市价每股0.075港元折让20%。
预期配售事项所得款项总额及所得款项净额分别为1200万港元及约1170万港元。现时预期(i)约420万港元将用以支付集团银行就两份新获授合约将发出的履约保证书;约630万港元将用作三份新获授合约的前置成本,当中包括购买原材料及劳工成本;及剩余部分约120万港元将由公司用作集团的一般营运资金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.